Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Austria Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20091
20101
20111
20121
20132
20141
20181
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
AstraZeneca2
Abbott Medical Devices1
CSL Behring1
Deutsches Herzzentrum Muenchen1
ECRI bv1
Eli Lilly and Company1
Gilead Sciences1
Medical University of Graz1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease13
Acute Coronary Syndrome3
Cardiovascular Diseases3
Atherosclerosis2
Coronary Stenosis2
Diabetes Mellitus, Type 22
Heart Diseases2
Myocardial Infarction2
Peripheral Arterial Disease2
Stroke2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.